Minerva Neurosciences (NERV) SEC Filings & 10K Form

$2.44
+0.01 (+0.41%)
(As of 04/26/2024 ET)

Recent Minerva Neurosciences SEC Filings

DateFilerForm TypeView
04/22/2024
4:07 PM
Minerva Neurosciences (Filer)
Form 10-K/A
02/27/2024
7:04 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
5:30 AM
Minerva Neurosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
8:28 AM
FMR LLC (Filed by)
Minerva Neurosciences (Subject)
Form SC 13G
01/18/2024
9:21 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Minerva Neurosciences (Subject)
Form SC 13G/A
11/07/2023
6:00 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/05/2023
3:32 PM
Ahlholm Frederick W (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
3:33 PM
Minerva Neurosciences (Issuer)
Race Geoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
3:34 PM
Luthringer Remy (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:57 AM
Laghrissi-Thode Fouzia (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:58 AM
Kupfer David (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:58 AM
HILLEMAN JERYL L (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
7:59 AM
Minerva Neurosciences (Issuer)
VAN HEEK G JAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
8:00 AM
HASLER HANS PETER (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
8:25 AM
Minerva Neurosciences (Filer)
Form DEF 14A
08/15/2023
8:26 AM
Minerva Neurosciences (Filer)
Form DEFA14A
08/15/2023
8:28 AM
Minerva Neurosciences (Filer)
Form ARS
08/09/2023
11:15 PM
Minerva Neurosciences (Filer)
Form EFFECT
08/04/2023
7:07 AM
Minerva Neurosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/01/2023
6:01 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/07/2023
3:18 PM
Boehringer AG (Filed by)
Minerva Neurosciences (Subject)
Form SC 13D
07/07/2023
3:15 PM
Boehringer AG (Reporting)
BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Reporting)
Minerva Neurosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
3:04 PM
Minerva Neurosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
06/28/2023
7:37 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
7:41 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
6:01 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2023
3:18 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
5:13 PM
Ahlholm Frederick W (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
5:14 PM
Minerva Neurosciences (Issuer)
Race Geoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
5:15 PM
Luthringer Remy (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2023
6:18 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NERV) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners